TLDR
- Lam Research (LRCX) reached a record peak of $274.42, delivering a 262% gain over the previous 12 months
- Third-quarter fiscal results exceeded projections; fourth-quarter outlook also surpassed Wall Street expectations
- TD Cowen upgraded its price objective to $340 from $290, reaffirming a Buy recommendation
- Multiple firms including UBS, Stifel, RBC, Cantor Fitzgerald, and TD Cowen maintain bullish ratings
- Management confirmed the company has already achieved its 2028 calendar year financial targets ahead of schedule
Lam Research (LRCX) soared to a fresh all-time peak of $274.42 during Thursday’s trading session, marking the culmination of an exceptional 12-month period that saw shares surge over 262%.
Lam Research Corporation, LRCX
Data from InvestingPro reveals the one-year gain totals 267%, with shares currently trading within 1% of the 52-week peak at $273.50.
The remarkable rally has been fueled by impressive financial performance and a wave of bullish analyst revisions throughout recent weeks.
Lam delivered fiscal Q3 earnings that outperformed both Stifel’s projections and broader market consensus. Additionally, the semiconductor equipment maker provided fourth-quarter guidance that exceeded expectations across both revenue expansion and profit margin metrics.
Executives highlighted that the organization has already achieved its previously outlined financial model targets for calendar 2028 and subsequent years — well before anticipated.
Wall Street Turns More Bullish
TD Cowen’s Krish Sankar elevated his price objective for LRCX to $340 from $290 this Wednesday while maintaining a Buy recommendation. Sankar recognized that skeptics may highlight limited potential upside following the robust June quarter projection and stretched valuation metrics, yet maintained that customer demand trends and profitability levels justify additional estimate revisions higher.
Stifel similarly kept its Buy stance while raising its target to $325, emphasizing the impressive quarterly performance.
RBC Capital boosted its objective to $310, highlighting robust demand driven by generative AI applications and expanding market share, coupled with an enhanced forecast for wafer fabrication equipment expenditures in 2026.
Cantor Fitzgerald maintained its Overweight designation with a $320 price objective, noting an improved outlook for wafer fabrication equipment throughout 2026 and 2027.
UBS reaffirmed its Buy rating, emphasizing Lam’s evolution into what analysts characterized as an AI-powered expansion phase.
Strong Financial Foundation Supports Rally
Lam’s underlying financials have strengthened in tandem with the share price appreciation. The semiconductor equipment manufacturer boasts a flawless Piotroski Score of 9, indicating exceptional financial health, while 20 analysts have revised earnings projections upward in recent reporting periods, per InvestingPro data.
TD Cowen’s Sankar acknowledged that critics will point to elevated valuation multiples following the strong guidance, but the firm maintains that robust customer demand and profitability trends remain constructive.
LRCX concluded Thursday’s session with approximately 4% gains, positioning shares at their newly established all-time record of $274.42.
